← All research updates

Focused radiation used again on 44 brain spots in one man

Original title: Case Report: Simultaneous stereotactic re-irradiation using HyperArc for 44 brain metastases after whole-brain radiotherapy.

How far along is this research?

This was tested in people. That is the most reliable kind of research we share.

This is a report on just one patient, so it is not yet proven as a treatment.

The short version

Doctors treated 44 brain tumor spots with focused radiation after whole-brain radiation: Radiation given to the whole brain, rather than aimed at one spot. It is used when there are too many tumors to aim at one at a time. See the glossary, and the spots stayed controlled.

What was studied. This is a report on one person, a 62-year-old man with small-cell lung cancer. He had more than 40 tumor spots in the brain. After whole-brain radiation: Radiation given to the whole brain, rather than aimed at one spot. It is used when there are too many tumors to aim at one at a time. See the glossary, doctors used a focused radiation method called HyperArc to treat 44 spots at once.

What they found. About ten months after whole-brain radiation: Radiation given to the whole brain, rather than aimed at one spot. It is used when there are too many tumors to aim at one at a time. See the glossary, scans showed 41 new spots and growth in 3 old ones. All 44 spots were treated with 21.0 Gy of focused radiation given in 3 sessions. Tests of thinking and memory were done before treatment and again after 4 and 12 weeks. They showed only small changes in some areas, and nothing the man noticed in daily life. No treated spot came back, and scans showed no radiation damage.

What this means, and what it doesn't

What it could mean: For a person with many brain spots that return after whole-brain radiation: Radiation given to the whole brain, rather than aimed at one spot. It is used when there are too many tumors to aim at one at a time. See the glossary, choices are limited. This report suggests focused radiation may be one option for some carefully chosen patients. It may help control the spots without a big drop in thinking.

What it doesn't mean: This is one man's story, not a study of many people. One good result cannot tell us how others will do. It does not prove this works better or safer than other care. It is not a cure, and it is not standard care. The doctors who wrote it say planned studies in more people are still needed.

Source: PubMed, September 24, 2026 · Read the original

This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.

Report a problem with this summary